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rnal of Stroke and CerBackground: Stroke is the main cause of cerebrovascular disease mortality. Prolonged stim-
ulation of N-methyl-D-aspartate (NMDA) receptor subtypes by the accumulation of gluta-
mate neurotransmitter in the extracellular space after a stroke could activate cell death
pathways. It is reported that progesterone provides different mechanisms of neuroprotec-
tion and could be considered as a candidate for stroke treatment. This study aimed to
investigate progesterone impact on the expression of NMDA receptor subunits NR1, NR2
(A and B), NR3 (A and B) after an experimental model of ischemic stroke which is followed
by an in silico analysis. Methods: Progesterone was introduced subcutaneously after tran-
sient middle cerebral artery occlusion in male rats. After a period of reperfusion, a set of
behavioral tests was performed to evaluate the postischemic neurological deﬁcits. The
2,3,5-triphenyltetrazolium chloride staining method was done for quantiﬁcation of infarct
volume and gene expression analysis was performed in the penumbra region using reverse
transcription polymerase chain reaction for NMDA receptor subunits. An AutoDock tool
was employed to performmolecular docking analyses for evaluation of progesterone inter-
action with NMDA receptor. Results: Cerebral ischemia caused a signiﬁcant downregula-
tion in NR1, NR2A, NR2B and a profound upregulation of NR3B in cortical penumbra
region. Treatment with progesterone resulted in upregulation of NR1, NR2A, and NR3B
which could explain a possible the neuroprotection of steroids via binding to NMDA gluta-
mate receptor. In addition, in silico analysis revealed that progesterone could strongly inter-
act with NR1/NR2B and NR2A. Conclusion: The ﬁndings elucidate a new aspect of the
neuroprotective mechanism of progesterone via NMDA receptors gene regulation.
Keywords: Stroke—NMDA receptor—Progesterone—Gene expression
© 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved.Introduction
Glutamate is the main neurotransmitter in the brain and
is required for normal synaptic function; it has also an
important role in neuronal growth and central nervous
systems development. Glutamate-mediated excitotoxicity
is one of the most important mechanisms that cause neu-
rotoxicity after stroke, so understanding its molecular
mechanisms can prevent ischemia damage.1 Brain tissue
is very vulnerable to ischemia that accounts for about 80%tral nervous systems; CBF, cerebral blood ﬂow; CC
al carotid artery; MCAO, middle cerebral artery o
tMCAO, transient MCAO
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ebrovascular Diseases, Vol.&&, N0.&& (&&of all strokes. Even a temporary blockade of blood ﬂow in
the brain could make a progressive damage to neurons.
So it is essential to understand glutamate-mediated
molecular mechanisms after stroke in order to provide
more effective therapeutics and decrease the stroke socio-
economic burden.2 N-methyl-D-aspartate (NMDA) recep-
tor is one of the most important glutamate-gated
transmembrane ion channel and functions at the postsyn-
aptic membrane of excitatory synapses in the central ner-
vous systems. Ischemic conditions cause accumulation ofA, common carotid artery; DMSO, dimethyl sulfoxide; ECA, external
cclusion; NMDAR, N-methyl-D aspartate receptor; NR, NMDA recep-
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leads to overactivation of NMDA receptor subtypes
(NMDARs) and increases Ca2+ inﬂux to the postsynaptic
neuron leading to excitotoxicity and downstream neuro-
nal death pathway activation.3 Previous studies showed
that NMDARs' subunit location and composition could
regulate neuronal survival or death.4 It is also reported
that ischemia changes the regulation of some NMDAR
subunits and pharmacological manipulation of these sub-
units could help to identify novel therapeutic strategies.
Neurosteroids have been shown to have modulatory
effects on NMDARs and could induce potentiation and/
or inhibition effects.5 Recently, it has been shown that pro-
gesterone (PROG) provides multiple mechanisms of neu-
roprotection and could be a suitable candidate for stroke
therapy.6
However, the effects of PROG on NMDAR subunit
expression have not yet studied completely. Regarding
the importance of NMDAR subunit composition in the
determination of receptor function, studying the inﬂuence
of PROG on their expression could result in more eluci-
dated knowledge about the neuroprotective mechanism
of the hormone. Therefore, this study aimed to investigate
the effect of PROG treatment on behavioral outcomes,
infarct volume, and gene expression of NR1, NR2A,
NR2B, NR3A, and NR3B subunits of NMDAR in an
experimental model of ischemic stroke in rats. In addition,
we performed an in silico analysis to assess the interaction
of PROG with NMDAR receptor.Materials and Methods
Experimental Groups
Male Wistar rats (16 weeks old, 240-300 g) were
obtained from domestic laboratory animal house (Kashan
University of Medical Sciences Animal House) and main-
tained in a 12 hour light/dark cycle with free access to
food and water. Experimental procedures were approved
by local Ethical Committee and were carried out in accor-
dance with Directive 2010/63/EU on the protection of
animals used for scientiﬁc purposes. Animals were ran-
domly divided into three groups: (1) control vehicle, (2)
vehicle-treated ischemia/reperfusion (I/R) group (ische-
mia), and (3) PROG-treated I/R group (ische-
mia + PROG). All tests were performed according to
guide to use and care of Laboratory Animals and
approved by the ethics committee of the Kashan Univer-
sity of Medical Sciences, Kashan, Iran.Focal Ischemia Animal Model and Hormone Treatment
Transient middle cerebral artery occlusion (tMCAO) was
used to prepare experimental stroke as described previ-
ously.7 Brieﬂy, anesthesia was induced by 5% isoﬂurane
using a vaporizer (Eickemeiyer, Germany) for 2-3 minutes
and maintained at 2%-3% during surgical procedures. Bodytemperature was maintained at 37 °C § 0.5 °C using a
warm pad (Narco Bio-Systems, Houston, Texas) and rectal
temperature was monitored during surgery (Nahavandi).
To assure a successful occlusion of the middle cerebral
artery, cerebral blood ﬂow (CBF) on both ipsi- and contralat-
eral hemispheres was measured by Laser-Doppler Flowme-
try (Moor Instruments VMS-LDF2, UK). Probes were
positioned and ﬁxed at »4-5 mm lateral and »1-2 mm pos-
terior to the bregma on right and left drill-thinned skull. A
small midline neck incision was made to expose the left
common carotid artery (CCA), internal carotid artery, and
external carotid artery. Vagus nerve was separated from the
CCA and a small incision performed on CCA using micro
scissors (Fine Science Tools, Canada). Then a silicon-coated
monoﬁlament (404356PK10Re, Doccol, Sharon, Massachu-
setts) introduced into the lumen of CCA and forwarded to
internal carotid artery at the bifurcation until a signiﬁcant
drop in CBF (>50% compared to baseline value). After 1 h
occlusion, monoﬁlament was removed carefully and the
reperfusion was occurred in the corresponding ischemic
region for 24 h. Sham animals were operated to the same
surgical steps, but the catheter did not introduce into the
CCA.10 mg/kg PROG (Sigma, Germany) was initially
diluted in pure ethanol, then diluted again in sesame oil to
the ﬁnal volume of 500 mL and was given as neck depots
immediately after MCAO induction. Dosage of the hormone
has been previously reported to gain the rapid physiologi-
cally high steroid plasma amounts (P » 70 ng/ml) with the
maximum of short-term protection.7 Sham animals received
an appropriate amount of ethanol/sesame oil mixture.
Behavioral Testing
Behavioral evaluation, including motor and sensory
tests, was applied to evaluate postischemic neurological
deﬁcits 24 h after tMCAO.8 The following six parameters
were evaluated:
1- Spontaneous activity: rats were placed in an
open environment (60 cm£ 90 cm sized cage)
and behavior was monitored for 3 minutes
(scores: 0 = not moving; 1 = hardly moving
around, but not rising up in the cage's wall;
2 =moving, but undecided to travel all the
cages, ultimately rising to at least one side of the
cage; 3 =moving around, exploring the environ-
ment, and approaching at least 3 walls of the
cage).
2- Forepaw outstretching: proximal part of the tail
was taken to evaluate outstretching of forelimbs
(scores: 0 = right forelimb entirely constricted;
1 = right side moves slightly; 2 = outstretching in
the right side is less than left side; 3 = symmetri-
cal outstretching in both forelimbs).
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der observing how they move to the top (scores:
1 = unable to climb or hold the wire; 2 = right
side is weak during climbing; 3 = climbing easily
and clutching the stair tightly).
4- Spontaneous activity: walking was checked
(scores: 0 = not walking; 1 =walking shift to the
right; 2 = right circling; 3 =walking straight
ahead).
5- Trunk proprioception: each side of the body was
touched with a blunt stick and the response to
the stimulus was assess (scores: 1 = not respond-
ing to the stimulus on right side; 2 = response to
the stimulus on right side slowly; 3 = moving
the head toward the stimulus and a symmetrical
manner on both sides).
6- Head proprioception: brushing was applied to
the vibrissae (scores: 1 = no response to the stim-
ulus on the right side; 2 = slow reaction to the
stimulus on the right side; 3 = turning the head
to the stimulus side). Finally, all individual test
scores were summed, and a total minimum
score of 3 and a total maximum score of 18 was
feasible.2,3,5-Triphenyltetrazolium Chloride Staining and
Quantiﬁcation of Infarct Volume
Twenty-four hours after tMCAO, rats were deeply
anesthetized by intraperitoneal injection of 10% chloral
hydrate; then sacriﬁced. Brains were removed and cut
into 2 mm coronal sections quickly by a rat brain matrix
(Zivic Instruments, Pittsburg, Pennsylvania). Brain slices
were soaked in a normal saline solution containing 1%
(w/v) 2,3,5-triphenyltetrazolium chloride (TTC) and incu-
bated at 37° for 20 minutes. In metabolic active tissue,
TTC is reduced into red 1,3,5-triphenylformazan in the
presence of mitochondrial dehydrogenase whereas infarct
area remains white.9 After arranging of the brain slices in
a frontal to occipital orientation, photos were taken using
a digital camera (Nikon, Japan). The ImageJ 1.44 software
(NIH, Bethesda, Maryland, USA) was used for evaluation
of the infarct area. Infarcted areas of ischemia-affected sec-
tions were measured (mm2) and multiplied by the thick-
ness of sections (2 mm) in order to get the infarction
volume of each brain.10
Analysis of Gene Expression in Cortical Peri-infarct
Region
For gene expression analysis, samples were taken from
tissues related to the peri-infarct area distinct in TTC-
stained sections, and tissues from the correspondingcontralateral area in the nonischemic hemisphere were
used as the control as described previously.9, 11 Total
RNA isolation from the peri-infarct area was performed
using the Peqgold total RNA extraction reagent (Peqlab,
Germany) and complementary DNA (cDNA) synthesis
was performed by cDNA synthesis kit (Invitrogen).
cDNA was diluted in 1:10 ratio and polymerase chain
reaction (PCR) was carried out in a 96£ 0.2 ml plate (Invi-
trogen, Carlsbad, California) containing a 5 ml SensiMix
master mix (Bioline, Germany), 1 ml of primers, 2 ml dis-
tilled water, and 2 ml of diluted cDNA. reverse transcrip-
tion PCR (RT-PCR) technology (BioRad, Germany) with a
standardized protocol was used to measure the gene
expression as described previously.12 Relative standard
curve method was performed by utilizing the house-
keeper gene hypoxanthine-guanine phosphoribosyltrans-
ferase (HPRT) as a reference gene. Primers used in the
study are summarized in Table 1.
Statistical Analysis
A total number of 22 rats were used in this study,
including sham (n = 6), ischemia (n = 8), and PROG
treated (n = 8). All data are presented as means § SEM
and analyzed with SPSS software (Ver. 22.0). For compari-
son of cerebral blood ﬂow (CBF) data, repeated measure-
ment ANOVA was used. The behavioral scores were
analyzed using KruskalWallis test. Ratios from real-
time relative quantity data were compared using one-way
ANOVA and post hoc Tukey's test. Differences were con-
sidered to be statistically signiﬁcant if p < 0.05.
In silico Analysis
Since neurosteroids could have modulating effects on
NMDA receptor, in this section of the study we evaluated
the interaction of PROG with NMDA receptor by a molec-
ular docking approach. For this purpose, at ﬁrst X-ray
crystallographic structures of NR1 (ID: 4NF8), NR2A (ID:
2A5S), NR2B (ID: 4NF8), NR3A (ID: 2AC7), and NR3B
(ID: 2RCA) molecules were obtained from the Research
Collaboratory for Structural Bioinformatics (RCSB) pro-
tein data bank (https://www.rcsb.org/). All of these
structures were related to rat species (Rattus norvegicus)
and they were selected with resolution less than 2. The
stability of structures was approved by Ramachandran
plot which prepared by RAMPAGE web server (http://
mordred.bioc.cam.ac.uk/»rapper/rampage.php). To cre-
ate the apoprotein structure, somemolecules such aswater,
ligands,etc.wereremovedfromproteindatabankstructures
byChimeraUCSFChimera(Ver.1.11.2)softwareandﬁnalthe
structureswereassessedbyConTEXTsoftware(Ver.0.98.6)to
ensureproper trimming.Finally,hydrogenandchargewere
added to all structures for docking purpose. In addition, 3-
dimensional structure of PROG(ID: 5994), glycine (ID: 750),
andglutamate(ID:33032)wereobtainedfromPubChemdata-
base. Treatment of these structures including energy
Table 1. Primer sequences, PCR product size, and annealing temperatures (AT) in real-time PCR
Gene Accession no. Primer sequence (5’!3’) TA ˚C Size (bp)
NR1 NM_001287423 AGTGGAACGGAATGATGGGCGA 57 262
ACTGAAGCGGTCCAGCAGGTA
NR2A NM_012573 GAGCCAGATGACAACCACCT 58 200
TCTTGAGGATGTCGATGCAG
NR2B NM_012574 CCAAGAGGAGGAAACAGCAG 56 184
TGAGGCGAGTTCTCCTTTGT
NR3A NM_138546 TAGGAAAGCCATTTGCCATC 56 202
GAAGTGCTTGATGCCCATTT
NR3B NM_133308 ACCGTGGCACTGTCTTCTCT 60 177
TCAAAGGTTTTGTCCCCAAC
HPRT NM_012583 GCTGGTGAAAAGGACCTCT 60 284
CACAGGACTAGAACACCTGC
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mer, addinghydrogenatoms to ensure thevalence of heavy
atoms,andaddingpartial chargeswereperformedbyAuto-
DockToolsoftware(Ver.1.5.6)fordockingprocedure.
For docking simulation, the proteins and the ligands
were loaded into AutoDock Tools. Gasteiger partial
charges were assigned after merging nonpolar hydrogen
and torsions applied to the ligands by all rotatable bonds.
Docking calculations were carried out on the protein
models. Polar hydrogen atoms Kallman charges and sol-
vation parameters were added with the aid of AutoDock
Tools. AutoDock Tool offers the option of three search
algorithms to explore the space of active binding with dif-
ferent efﬁcacy. We used the Lamarckian genetic algorithm
(LGA) in this study. Docking was performed for each of
the subunits of NMDA and near the NR1NR2A and
NR1NR2B dimer interface. Information on the binding of
hydrogen and the grid is fully listed in Table 2. For each
of them, 50 independent runs implementations are consid-
ered. Then, LigPlot+ (Ver. 1.4.5) and Chimera UCSF (Ver.
1.11.2) were used to visualize the complex protein pattern
of the ligand.
Results
CBF, Behavioral Deﬁcits, and Infarct Volume Analyses
To make sure a successful tMCAO, CBF on both ipsi-
and contralateral sides was measured in both ischemicTable 2. Results of molecular docking
NMDAR subunits LBE (kcat/mol) Number of HB RMSD
NR1 7.81 1 0.56
NR2A 7.97 2 0.0
NR2B 7.55 1 0.04
NR3A 6.8 1 0.83
NR3B 7.24 1 0.0
NR1NR2A 6.07 1 0.0
NR1NR2B 10.66 1 0.0
Abbreviations: CGB, center grid box; , HB, hydrogen bonds; LBE, lowand treated groups which are described in “Materials and
Methods” section. Data from Laser-Doppler ﬂowmetry
showed that after tMCAO, the regional CBF values
decreased to >60% compared with pre-ischemic values.
Also, this value was stable during the occlusion (Fig. 1A).
As depicted in Figure 1(A), there was no signiﬁcant differ-
ence between ischemic and treated groups. Mean values
reduced to »60% in both ischemic and treated groups
compared with baseline values.
As shown in Fig. 1(B), tMCAO signiﬁcantly reduced the
maximum score from 18 in sham-operated animals to »12
in tMCAO group. Also, scoring of each subcategory was
comparable separately (data are not shown). The PROG
treated ischemic rats showed signiﬁcantly improved
behavioral outcomes (P < 0.01) and reduced infarct vol-
ume (P < 0.05). The extensive infarct volume was
observed in the striatum and cortex of control group and
reduced signiﬁcantly after treatment with PROG, espe-
cially in the cortex region (P < 0.05; Fig. 2).Expression of NMDA Receptor Subunits in the Peri-
infarct Area
The data from real-time PCR revealed that after stroke,
the mRNA expression of NMDAR subunits NR1, NR2A,
and NR2B were downregulated, while the expression of
NR3B was upregulated signiﬁcantly (P < 0.001). The
treatment of PROG resulted in upregulation of NR1 (P <for different subunits of NMDAR
Residues involved in HB CGB
His12 x:19.52; y:42.464; z:38.253
Lys41, Val197 x:26.718, y:22.536, z:32.318
Val197 x:32.033; y:72.96; z:10.748
Ser144 x:10.956; y:46.687; z:0.532
His15 x:53.293; y:21.804; z:20.121
Leu244 x:15.131; y:-15.16; z:35.727
Glu133 x:40.472; y:75.404; z:26.083
est binding energy; RMSD, Root mean square deviation.
Figure 1. Measurement of CBF over the middle cerebral artery territory before, during (60 minutes), and after tMCAO. (A) Decrease in CBF shown as percent-
age of baseline values and the CBF increases after tMCAO. tMCAO signiﬁcantly reduced the maximum score from 18 in sham-operated animals without
tMCAO to »12. (B) The PROG-treated ischemic rats showed signiﬁcantly improved behavioral outcomes (P < 0.01).
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NR3A subunit expression was not inﬂuenced signiﬁcantly
after strokes while this subunit was downregulated after
treatment with PROG (Fig. 3).Docking Results
The complex of NMDAR including two NR1 and NR2B
has been shown in Figure 4. As shown, NR1 subunit could
interact with glycine and NR2B could bind to glutamate.
Results of molecular docking including lowest binding
energy (kcal/mol), number of hydrogen bonds, root
mean square deviation (RMSD), and residues involved in
H-binding are detailed in Table 2. The data revealed that
the PROG could bind to NMDAR near the glycine bind-
ing site of NR2A with lowest binding energy equal toFigure 2. Changes of infarct volume after hormone treatment. (A) The infarct volu
from the measurement of infarct volume in the ischemia and treated with PROG gro7.97 kcal/mol (Table 2). Also, the data showed that the
PROG could strongly interact with dimmer interface of
NR1/NR2B heterodimer with lowest binding energy
equal to 10.66 kcal/mol (Fig. 5). The 2-dimensional anal-
ysis showed that the hydrogen bond will be established
between Glu113 of NR2B and oxygen linked to carbone
20 of PROG (Fig. 5).Discussion
The vast majority of deaths from cerebrovascular dis-
eases are due to stroke, the second leading cause of mor-
tality and also one of the leading causes of morbidity
worldwide.13 The burden of disease is great and in order
to lessen it by providing effective therapeutics, under-
standing the molecular mechanisms involving strokeme in sham, stroke (I/R), and treated with PROG (IR+P) groups. (B) Results
ups (*P < 0.05).
Figure 3. Expression pattern of NMDA receptor subunits in peri-infarct area. After MCAO the gene expression of NMDAR subunits NR1, NR2A, and NR2B
was downregulated, while the expression of NR3B was upregulated signiﬁcantly (P < 0.001). The treatment of PROG resulted in upregulation of NR1 (P <
0.05), NR2A (P < 0.01), and NR3B (P < 0.01) signiﬁcantly. The NR3A expression was not inﬂuenced signiﬁcantly after MCAO while this subunit downregu-
lated after treatment with PROG. (*indicates signiﬁcant P-value ischemia versus control; # indicates signiﬁcant P-value ischemia + PROG versus ischemia).
The P-values are indicated as # and *: P  0.05; ## and **: P  0.01; ### and ***: P  0.001. (A total number of 22 rats were used in this study, including sham
[n=6], ischemia [n=8], and progesterone treated [n=8]).
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hormone could provide neuroprotective effects and here
we aimed to investigate the possible relationship betweenFigure 4. Ribbon structure of NMDAR. NMDAR ligand binding domains havin
binds to glutamate.PROG protective mechanisms after stroke with NMDA
receptor. In this study, we evaluated the infarct volume
after stroke and treatment with PROG. Our data revealedg two subunits including NR1 (blue) binds to glycine and NR2B (orange)
Figure 5. Interaction of NMDAR with progesterone. (A) Rounded ribbon structure of NMDAR ligand binding domains having two subunits including NR1
and NR2B in complex with progesterone; NR1, NR2B, and progesterone indicated with blue, orange, and green, respectively. (B) The two-dimensional analysis
showed an established hydrogen bound between Glu113 of NR2B and oxygen linked to carbone 20 of progesterone. The conventional hydrogen bond is shown by
blue arrowhead.
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tum and cortex of ischemia group. Consistent with previ-
ous reports, we showed that treatment with PROG
reduces infarct volume signiﬁcantly.14, 15 Also, we ana-
lyzed stroke-induced functional damages in the rats after
tMCAO. As shown in Figure 1(B), tMCAO signiﬁcantly
reduced the maximum score from 18 in sham-operated
animals to »12 in ischemia group. The peri-infarct area is
well deﬁned as the area adjacent to ischemic area. A
broadly established deﬁnition of the peri-infarct area is
“ischemic tissue potentially destined for infarction but not
yet irreversibly injured and the target of acute thera-
pies.”16 The area of infarcted tissue in the brain is one of
the main results of stroke. Ishrat et al. (2009) declared that
a short course of postinjury treatment with PROG reduces
cortical infarct volume and leads to an attenuation of the
deﬁcits after MCAO in rats.17
We also analyzed the expression levels of NMDA recep-
tor subunits namely NR1, NR2A, NR2B, NR3A, and
NR3B in the peri-infarct area after treating animals with
PROG immediately after stroke. Our data revealed that
the expression of NMDAR subunits NR1, NR2A, and
NR2B was downregulated after tMCAO signiﬁcantly,
while the expression of NR3B was highly upregulated in
the peri-infarct area compared to control. Also, the expres-
sion of NMDA subunits was analyzed in the presence of
PROG. Our data revealed that subunits NR1, NR2A, and
NR3B were signiﬁcantly upregulated in the presence of
PROG after stroke in peri-infarct area. Expression of
NR2B did not change after PROG treatment whereas
NR3A subunit was downregulated signiﬁcantly.
There are a variety of different subtypes of NMDAR due
to their multiple combinations of individual subunits
(NR1, NR2A-D, and NR3A-B) which are coded by seven
genes. Sensitivity to Mg2+ ion, calcium permeability, and
glutamate afﬁnity of a NMDAR, is partly determined by
its subunit composition.18 Indeed, NMDAR subunit com-
position and location differentially regulates neuronalsurvival or death.4 Evidence suggests that synaptic
NMDARs are involved in neuronal survival while the
extrasynaptic NMDAR activity is correlated with cell death
pathway.19 In synapses of the adults’ brain, NR2A contain-
ing NMDARs are predominant; while extrasynaptic
NMDARs predominantly contain NR2B.20 Investigations
have shown that following ischemia and NDMAR activa-
tion, NR2B-containing receptors promote neuronal death
signals,20, 21 while NR2A and NR3 subunit containing
receptors mediate neuronal survival signaling pathways.19,
22 In ischemic brain, Ca2+-dependent protease calpain,
cleaves NR2A and NR2B subunits at their C-terminal
domains23 and serves as a negative feedback molecule to
NMDA function.24 The NR3A and NR3B subunits act as
dominant negative regulators of the NMDAR current and
have been shown to reduce the Ca2+ permeability of the
NMDAR and alter Mg2+ sensitivity. The NR3A subunit
has been shown to form excitatory glycinergic receptor
complexes with NR1 alone and glutamatergic receptor
complexes with NR1 and NR2 subunits. Exogenously
added NR3A increases neuroprotection and endogenous
NR3A protects neurons.22 The distribution of NR3B
appears to be as ubiquitous as NR1 and it is found to be
expressed in motor neurons of the spinal cord, different
cell types of the cerebellum, interneurons of the striatum,
projection neurons, and layers of the cerebral cortex and all
substructures of the hippocampus.25,26 NR3B may modu-
late the function of NMDARs in somatic motor neurons
during adulthood by controlling membrane trafﬁcking and
by reducing Ca2+ permeability. Since the high Ca2+ perme-
ability is a key feature for NMDARs to play critical roles in
neurodevelopment, synaptic plasticity, and neuronal
death, NR3B may contribute to the regulation of these
physiological and pathological processes.27 NR3B, when
exogenously introduced into hippocampal neurons, can
co-assemble with endogenous NR1 and NR2A and can
reduce the Ca2+ permeability of NMDA currents. In con-
trast, NR3B is not involved in the excitatory glycine
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NMDARs is likely to switch from NR2 to NR3B in somatic
motoneurons during the early postnatal period.28 PROG
provides multiple mechanisms of neuroprotection includ-
ing alteration of gene expression proﬁle after stroke in peri-
infarct area.6 This prompted us to evaluate the expression
levels of NMDAR subunits by means of RT-PCR. Our
results showed that PROG elevates NR1, NR2A, and NR3B
subunit expression, among them NR2A and NR3B are neu-
roprotective and NR1 is crucial for the assembly of
NMDARs in all areas of the brain. Although NR3A is a
protective factor, PROG reduced its expression after ische-
mia. PROG did not upregulate NR2B subunit expression
which promotes neuronal death. Then, PROG may do
some parts of its neuroprotective function by elevation of
NMDAR subunits that are involved in neuronal survival.
A variety of biochemical and molecular alterations
occur in the place following the stroke. Excessive intracel-
lular Ca2+ increases through glutamate receptor activa-
tion, particularly NMDAR, which can cause
mitochondrial ultrastructural changes and a calcium-
dependent opening of mitochondrial permeability transi-
tion pore.29 The Ca2+ inﬂux through the opened NMDAR
into the postsynaptic cell activates second messengers
which are responsible for long-lasting synaptic plastic-
ity.30 Excitotoxicity and Ca2+ overload are major factors
contributing to the early stages of ischemic cell death. If
glutamate neurotransmitter accumulates into the extracel-
lular space, it will lead to prolonged stimulation of
NMDAR subtypes to dramatically enhance the inﬂux of
calcium into neurons that it activates catabolic processes
mediated by proteases, lipases, and nucleases. In the case
of steroids and NMDARs, Boon et al.’s (2005) ﬁndings
showed that selective loss of estrogen synthesis is associ-
ated with changes in NMDAR subunit expression in the
hippocampus.31 Also, it is shown that estradiol and selec-
tive estrogen receptor modulators could modulate NR1
and NR2B subunits in ovariectomized rats.32 The steroid
hormone PROG also has effects on NMDAR and inhibits
receptor-gated rise in intracellular Ca2+ after brain injury
that is expected to result in the prevention of neuronal
death. PROG has been shown to attenuate the rise of
intracellular calcium by its effects on both the receptor-
gated and the voltage-gated channels after focal cerebral
ischemia in vivo or in striatal neurons in vitro.33 Indeed,
PROG provides multiple mechanisms of neuroprotection
that could be very important after stroke, such as reduc-
ing cerebral edema, as well as anti-inﬂammatory, antioxi-
dant, antiapoptotic, and antiexcitatory properties.6
The heteromeric NR1/NR2 receptors activation requires
the concurrent binding of two glycine molecules and two glu-
tamate molecules.34 These activated molecules are permeable
for K+ and Na+ ions and also have a great efﬁciency for Ca2+.
It is interesting that NR1, NR3A, and/or NR3B subunits can
create the functional purely glycine-activated channels that
furthermore vary from NR1/NR2-containing receptors inother features, including low calcium permeability.5 There-
fore, increasing the expression of NR3B in improving the
stroke after PROG therapy seems reasonable. Neurosteroids
regulate gene expression through speciﬁc DNA-binding sites.
Two hormone response elements are well known for the ste-
roid receptors: AGGTCA is desired for estrogen receptor, and
AGAACA is desired for the glucocorticoid receptors, which
includes mineralocorticoid receptor, androgen receptor, and
PROG receptor.35, 36 The up-stream region ofNR3B gene con-
tains the deﬁned hormone response elements (AGAACA)
and this could conﬁrm the upregulation ofNR3B by PROG.
This study was designed to evaluate neuroprotective
effects of steroid in the acute phase of the stroke; there-
fore, we analyzed infarction size and behavioral test 24
hours after tMCAO. However, steroid hormones such as
estrogen and PROG could have long-term neuroprotec-
tive effects. Ulbrich et al. (2012) reported that estrogen
and PROG could have protective effects on infarction vol-
ume and behavioral parameters 7 days and 14 days after
tMCAO. Their outcomes propose that the neuroprotective
effectiveness of estrogen and PROG is continued and per-
severes for at least 14 days. Also, antiapoptotic and anti-
inﬂammatory actions and angiogenesis in the injured
region seems to be primarily affected early after tMCAO
and is demonstrated up to 14 days.37
Assessing the molecular interactions through experiential
tests is a very difﬁcult procedure.38 But the use of computa-
tional devices can be a worthy method to overcome this
issue.39 Therefore, in another part of our study, we performed
a molecular docking approach to analyze the interaction of
PROG with different subunits of NMDAR. Brieﬂy, our data
revealed that PROG could interact with NR1/NR2B and
NR2A subunits, strongly. NMDARs are modulated by a vari-
ety of synthetic and endogenous steroids displaying potenti-
ating or inhibitory effects.40-42 The general trait of all steroid
compounds that modulate the function of NMDAR is the
existence of a charged group on the carbon C3 belonging to
the steroid core.43 Therefore, the interactions of PROG with
NMDAR may modulate the effects of NMDAR during
tMCAO. So estrogen can play a dual role here: (1) alteration
of NMDAR gene expression and (2) modulation of NMDAR
function.
Despite the extent evidence for the beneﬁcial effects of
PROG following insults such as traumatic brain injury,
stroke, and excitotoxicity, the exact mechanism (s) by
which PROG exerts these neuroprotective effects remain
elusive.44 These ﬁndings suggest that the acute neuropro-
tection of PROG is involved in NMDAR-Ca2+ inﬂux.
We should mention that the absence of the analyses in a
protein level of NMDAR subunits is the main limitation
of this study. In conclusion, the PROG-treated ischemic
rats showed signiﬁcantly improved behavioral outcomes
and reduced infarct volume. After MCAO the expression
of NMDAR subunits NR1, NR2A, and NR2B were down-
regulated, while the expression of NR3B upregulated sig-
niﬁcantly. The treatment of PROG resulted in
ARTICLE IN PRESS
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expression was not inﬂuenced signiﬁcantly. Our study
showed that increasing the expression of downregulated
NMDAR subunits may be part of a possible neuroprotec-
tive mechanism of PROG in ischemic rats.
Conﬂict of Interest: The authors declare that there are no
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